IMS – The Impact of Biosimilar Competition (2016)

Biosimilar medicines critical for future medicines access… 13 December 2023 By 2032, the biosimilar medicines contribution to health systems access…
IQVIA - Assessing the Biosimilar Void 30 October 2023 While biosimilar competition in Europe has played a vital role…
New IQVIA report points to window of opportunity for the EU… 26 October 2023 The EU is currently reviewing its Pharmaceutical Legislation, and the…
Maximising the impact of Biosimilar Medicines requires… 5 December 2024